Five Prime Therapeutics

Home » Five Prime Therapeutics

Secondary

Five Prime Therapeutics

They are a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics.

Symbol

FPRX

Last Closing Price
$20.14

Shares
3,400,000

Effective Date
January 25, 2018

Underwriters
Goldman Sachs & Co., J.P. Morgan, Leerink Partners, Wells Fargo

To view the prospectus for Five Prime Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253